Dorsal root ganglion stimulation provides significant functional improvement from acute debilitating Crohn's disease: A novel use
- PMID: 39239493
- PMCID: PMC11373045
- DOI: 10.1016/j.inpm.2024.100389
Dorsal root ganglion stimulation provides significant functional improvement from acute debilitating Crohn's disease: A novel use
Abstract
Crohn's disease is a chronic inflammatory bowel condition causing symptoms, notably pain, due to ongoing intestinal inflammation or complications like abscesses, strictures, and fistulas, which are common in IBD patients. Abdominal pain affects up to 60 % of IBD patients, irrespective of disease severity, prompting medical attention. Various medications like NSAIDs, antidepressants, antispasmodics, anticonvulsants, and opioids are used to manage pain, but they have limited effectiveness and potential side effects, even during remission. In this case, a 20-year-old Caucasian female college student [height 5'4″, weight 120lbs (54.4 kg)] with juvenile idiopathic arthritis and Crohn's disease experienced severe daily abdominal pain, negatively impacting her life. Despite a multimodal regimen, including gabapentin, nortriptyline, duloxetine, and acetaminophen, her pain persisted, significantly affecting her appetite, sleep, mood, activity level, and overall quality of life (QOL). To address this, dorsal root ganglion (DRG) stimulation was considered. The patient aimed for a 20 % pain reduction and improved QOL. Trial leads were placed along the T10 and T12 DRG, resulting in a 25 % pain reduction (8-6 out of 10) and substantial QOL improvement. She could eat, sleep without interruptions, walk longer distances, and be more active. The T12 lead was more effective than the T10, targeting upper abdomen stimulation. The patient and her mother were highly satisfied and opted for permanent implantation for the T11 and T12 DRG. While DRG stimulation was approved in 2016 for chronic pain, to our knowledge, this is the first reported case of its use in a patient with debilitating Crohn's disease.
Keywords: Acute pain crisis; Crohns; DRG; IBD; IBD flare; Neuromodulation; Neuropathic pain.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Dorsal root ganglion stimulation provides functional improvement from debilitating abdominal pain in Crohn's disease: A 12-month follow-up.Interv Pain Med. 2024 Dec 2;3(4):100524. doi: 10.1016/j.inpm.2024.100524. eCollection 2024 Dec. Interv Pain Med. 2024. PMID: 39697857 Free PMC article.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
T12 Dorsal Root Ganglion Stimulation to Treat Chronic Low Back Pain: A Case Series.Neuromodulation. 2020 Feb;23(2):203-212. doi: 10.1111/ner.13047. Epub 2019 Oct 6. Neuromodulation. 2020. PMID: 31588662 Clinical Trial.
-
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.Gastroenterology. 2024 Mar;166(3):521-532. doi: 10.1053/j.gastro.2023.11.303. Epub 2024 Jan 23. Gastroenterology. 2024. PMID: 38276922
-
The Pathways and Processes Underlying Spinal Transmission of Low Back Pain: Observations From Dorsal Root Ganglion Stimulation Treatment.Neuromodulation. 2021 Jun;24(4):610-621. doi: 10.1111/ner.13150. Epub 2020 Apr 23. Neuromodulation. 2021. PMID: 32329155 Review.
Cited by
-
Dorsal root ganglion stimulation provides functional improvement from debilitating abdominal pain in Crohn's disease: A 12-month follow-up.Interv Pain Med. 2024 Dec 2;3(4):100524. doi: 10.1016/j.inpm.2024.100524. eCollection 2024 Dec. Interv Pain Med. 2024. PMID: 39697857 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials